• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Efficient chromatographic reduction of ovalbumin for egg-based influenza virus purification

tetano

Editor, Senior Moderator
Vaccine. 2014 May 3. pii: S0264-410X(14)00559-3. doi: 10.1016/j.vaccine.2014.04.033. [Epub ahead of print]
Efficient chromatographic reduction of ovalbumin for egg-based influenza virus purification.
Blom H1, Akerblom A2, Kon T3, Shaker S3, van der Pol L3, Lundgren M2.
Author information
Abstract

Vaccination is the most effective prevention strategy to avoid influenza infection and for protection of large populations. The vast majority of influenza vaccines are still produced with allantoic fluid from fertilized chicken eggs. The presence of ovalbumin, which can constitute over 60% of the total protein content in allantoic fluid, can result in severe allergies. Consequently, efficient reduction of ovalbumin is critical during vaccine manufacturing. Here we present Capto Core 700, a novel core bead chromatographic flow through mode resin for removal of ovalbumin and compare it to sucrose zonal gradient ultracentrifugation, which is the industry standard for egg-based vaccine production. The results demonstrate that core bead chromatography is fully comparable to zonal centrifugation in removing ovalbumin to meet regulatory requirements. Furthermore, the scalability and the shorter process times of this method have the potential to significantly improve the productivity and economy for industrial production compared to zonal centrifugation.

Copyright ? 2014. Published by Elsevier Ltd.
KEYWORDS:

Allantoic fluid, Core bead chromatography, Influenza, Ovalbumin, Ultracentrifugation

PMID:
24801053
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24801053
 
Back
Top Bottom